Ambry Genetics Launches A New Generation Of Clinical Exome Sequencing

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics (“Ambry”) announces the launch of ExomeNext™ and ExomeNext-Rapid™ at the American College of Medical Genetics (ACMG) conference today in Nashville. The new assays feature lower turnaround times, lower pricing, more comprehensive coverage and a new expedited option called ExomeNext-Rapid™ for severe clinical cases that require an immediate answer for clinical management purposes; for example, NICU patients whose care and outcome can be significantly impacted by rapid identification of a genetic explanation.

Help employers find you! Check out all the jobs and post your resume.